串签技术联合超声乳化术摘出脱位入玻璃体腔的晶状体
本研究评估新开发的串签技术处理晶状体脱位的疗效与安全性,共治疗21眼,术后3个月最佳矫正视力较术前显著改善,所有眼均未发生术中或术后视网膜损伤,作者认为该技术安全可行。
要点
- 串签技术联合超声乳化术可用于摘出脱位入玻璃体腔的晶状体。
- 术后3个月最佳矫正视力较术前显著改善。
- 所有治疗眼均未发生术中或术后视网膜损伤。
核心结论
- 作者认为其开发的串签技术是处理晶状体脱位的创新解决方案,基于一系列接受该手术患者的术后结果,该技术高度安全且可行。
研究设计与样本
- 共21眼晶状体脱位接受该手术技术治疗,重点观察术后3个月最佳矫正视力、眼压和视网膜损伤并发症。
主要发现
- 患者平均年龄60.20±10.73岁(范围41-85岁),平均眼轴长度25.40±2.35 mm(范围22.30-32.35 mm)。
- 术后3个月最佳矫正视力较术前测量显著改善。
- 所有接受该新技术治疗的眼均未发生术中或术后视网膜损伤。
临床怎么用
- 作者描述该技术可在前房内利用光导控制晶状体的位置和移动来完成超声乳化,从而免去使用全氟碳液体或广泛睫状体平坦部巩膜切开的需要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the efficacy and safety outcomes of our newly developed skewer technique in the management of lens dislocation. METHODS: A total of 21 eyes with lens dislocation were treated with this surgical technique. We focused on best-corrected visual acuity (BCVA), intraocular pressure, and complications of retinal damage at 3 months post-surgery. RESULTS: The mean age of the patients was 60.20 ± 10.73 (range: 41-85) years, and the average axial length was 25.40 ± 2.35 (range: 22.30-32.35) mm. The BCVA at 3 months post-surgery showed a significant improvement compared to preoperative measurements. No intraoperative or postoperative retinal damage occurred in any eyes treated with this new technique. CONCLUSION: The "skewer" technique we developed is an innovative solution for addressing lens dislocation. Phacoemulsification can be performed in the anterior chamber utilizing a light guide to control the position and movement of the lens. This approach eliminates the need for perfluorocarbon liquid or extensive pars plana scleral sclerotomy. Based on postoperative outcomes from a series of patients who underwent this procedure, the technique is highly safe and feasible.
引用
- Zhou Z, Guo B, Lin Z, et al. The skewer technique combined with phacoemulsification to remove the lens dislocated into the vitreous cavity. Retina. 2024. PMID: 39423162. doi:10.1097/IAE.0000000000004305
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。